21 CFR 200.7
§ 200.7 Supplying pharmacists with indications and dosage information.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 200.7, § 200.7 Supplying pharmacists with indications and dosage information, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/85737
- Permanent ID
ys:prov:85737@1- SHA-256
25e2bd9df318983a8e175b6c28a44ad52b9adf838d7563ffb99eeb6cc87cf105
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
There are presently no regulations under the Federal Food, Drug, and Cosmetic Act that prevent a manufacturer of prescription drugs from sending the pharmacist data he needs on indications and dosage in exercising his important professional function of checking against possible mistakes in a prescription. The Food and Drug Administration believes manufacturers should be encouraged to supply such printed matter to the pharmacist for his professional information. Obviously, such printed matter should not be displayed to prospective purchasers to promote over-the-counter sale of prescription drugs.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.